A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.
about
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A Phase 1 study of ARQ 087, an ...... s with advanced solid tumours.
@en
A Phase 1 study of ARQ 087, an ...... s with advanced solid tumours.
@nl
type
label
A Phase 1 study of ARQ 087, an ...... s with advanced solid tumours.
@en
A Phase 1 study of ARQ 087, an ...... s with advanced solid tumours.
@nl
prefLabel
A Phase 1 study of ARQ 087, an ...... s with advanced solid tumours.
@en
A Phase 1 study of ARQ 087, an ...... s with advanced solid tumours.
@nl
P2093
P2860
P356
P1476
A Phase 1 study of ARQ 087, an ...... s with advanced solid tumours.
@en
P2093
A W Tolcher
B F El-Rayes
G Abbadessa
J C Sachdev
K P Papadopoulos
P M LoRusso
R D Harvey
P2860
P2888
P304
P356
10.1038/BJC.2017.330
P407
P577
2017-10-03T00:00:00Z
P6179
1092053554